Since common epithelial cancers are resistant to most therapeutic treatments, much hope has been placed on prevention of cancer through the use of chemical agents or dietary manipulation. The widely used nonsteroidal antiinflammatory drugs (NSAIDs) are effective in chemoprevention of colorectal cancer, which is the second leading cause of cancer related death in the United States. However, the mechanisms underlying the anti-neoplastic effects of NSAIDs remain unclear. Substantial evidence has indicated that the chemopreventive activities of NSAIDs are mediated by induction of apoptosis. Our recent preliminary studies demonstrated that SMAC, a mitochondrial apoptogenic protein, plays an essential role in NSAID- induced apoptosis in colon cancer cells. SMAC is consistently released from the mitochondria into the cytosol during NSAID-induced apoptosis. Deletion of SMAC by homologous recombination or knockdown of SMAC by RNA interference in these cells abrogates NSAID-induced caspase activation and apoptosis. Furthermore, activation of SMAC and agents that mimic the function of SMAC can enhance the apoptotic response to sulindac, an NSAID commonly used in chemoprevention. These observations led us to hypothesize that SMAC mediates the anti-neoplastic effects of NSAIDs by promoting apoptotic cell death. We propose to test this hypothesis in vitro and in vivo using a combination of biochemical and genetic approaches. In the Aim 1, we will delineate the mechanisms by which NSAIDs induce SMAC release and apoptosis in colon cancer cells. We will focus on studying how NSAIDs modulate Bax and Bcl-XL to cause SMAC release and apoptosis. In the Aim 2, we will use cell culture and APCMM+ mouse models to determine if SMAC and SMAC mimetics sensitize the effects of NSAIDs in vitro and in vivo. In the Aim 3, we will use cell culture and xenograft tumor models to investigate if active SMAC and SMAC mimetics can restore NSAID sensitivity in NSAID-resistant colon cancer cells in vitro and in vivo. Finally, we will determine in the Aim 4 if SMAC is necessary for sulindac-mediated chemoprevention, and if other mitochondrial apoptogenic proteins mediate the effects of sulindac. The proposed studies will provide new insights into the anti-neoplastic effects of NSAIDs. In the long run, the results of these studies could be useful for developing improved strategies and agents for chemoprevention of colon cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA121105-05
Application #
8119724
Study Section
Chemo/Dietary Prevention Study Section (CDP)
Program Officer
Perloff, Marjorie
Project Start
2007-09-01
Project End
2013-07-31
Budget Start
2011-08-01
Budget End
2013-07-31
Support Year
5
Fiscal Year
2011
Total Cost
$263,626
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Tong, Jingshan; Wang, Peng; Tan, Shuai et al. (2017) Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells. Cancer Res 77:2512-2521
He, K; Zheng, X; Li, M et al. (2016) mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation. Oncogene 35:148-57
Chen, Xiaojun; Song, Xiaomeng; Yue, Wen et al. (2015) Fibulin-5 inhibits Wnt/?-catenin signaling in lung cancer. Oncotarget 6:15022-34
Brown, M F; Leibowitz, B J; Chen, D et al. (2015) Loss of caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis. Cell Death Dis 6:e1729
Wang, Xinwei; Wei, Liang; Cramer, Julie M et al. (2015) Pharmacologically blocking p53-dependent apoptosis protects intestinal stem cells and mice from radiation. Sci Rep 5:8566
Sun, Jing; Knickelbein, Kyle; He, Kan et al. (2014) Aurora kinase inhibition induces PUMA via NF-?B to kill colon cancer cells. Mol Cancer Ther 13:1298-308
Leibowitz, Brian; Qiu, Wei; Buchanan, Monica E et al. (2014) BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A 111:16520-5
Chen, Dongshi; Ming, Lihua; Zou, Fangdong et al. (2014) TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity. Oncotarget 5:8107-22
Kim, Seog-Young; Song, Xinxin; Zhang, Lin et al. (2014) Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death. Biochem Pharmacol 88:178-88
Chen, Dongshi; Wei, Liang; Yu, Jian et al. (2014) Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis. Clin Cancer Res 20:3472-84

Showing the most recent 10 out of 39 publications